Literature DB >> 8071758

Intramuscular versus enteral vitamin A supplementation in very low birth weight neonates.

M G Rush1, J P Shenai, R A Parker, F Chytil.   

Abstract

We conducted a randomized trial in very low birth weight neonates (n = 51) to determine whether vitamin A supplementation by enteral administration would increase plasma vitamin A concentrations to the same degree as by intramuscular administration. Mean plasma vitamin A concentrations were significantly higher in the intramuscular-administration group than in the enteral-administration group by postnatal day 7; this effect persisted throughout the remainder of the trial. At the dosage used in this trial, vitamin A supplementation by the enteral route is not as effective as that by the intramuscular route in very low birth weight neonates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071758     DOI: 10.1016/s0022-3476(05)83295-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

Review 1.  Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants.

Authors:  Brian A Darlow; P J Graham; Maria Ximena Rojas-Reyes
Journal:  Cochrane Database Syst Rev       Date:  2016-08-22

2.  Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease.

Authors:  S P Wardle; A Hughes; S Chen; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-01       Impact factor: 5.747

Review 3.  Nutritional Supplements to Improve Outcomes in Preterm Neonates.

Authors:  Mohan Pammi; Ravi M Patel
Journal:  Clin Perinatol       Date:  2022-04-21       Impact factor: 2.642

4.  Vitamin A to prevent bronchopulmonary dysplasia in extremely low birth weight infants: a systematic review and meta-analysis.

Authors:  Shunsuke Araki; Shin Kato; Fumihiko Namba; Erika Ota
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

5.  Inhaled vitamin A is more effective than intramuscular dosing in mitigating hyperoxia-induced lung injury in a neonatal rat model of bronchopulmonary dysplasia.

Authors:  Craig A Gelfand; Reiko Sakurai; Ying Wang; Yitian Liu; Robert Segal; Virender K Rehan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-05       Impact factor: 6.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.